Roadzen vs Zhibao Technology
RDZN and ZBAO side by side, both in insurance agents, brokers, and service. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How RDZN and ZBAO compare
Zhibao Technology grew revenue faster over the last twelve months (50.8% versus 30.5% for Roadzen).
Zhibao Technology keeps more of each dollar of sales as profit, with a net margin of −22.4% compared with −46.9% at Roadzen.
Zhibao Technology scores higher on the StockData Score (3 against 2 for Roadzen), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | RDZN | ZBAO |
|---|---|---|
| Size and price | ||
| Market cap | $82.8M | – |
| Share price | $0.972 | $0.279 |
| Change, 1 year | −31.0% | −99.4% |
| Beta (5Y) | 0.78 | 1.63 |
| Employees | 458 | 65 |
| StockData Score | ||
| Total score | 2 | 3 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 1 | 3 (better) |
| Performance score | 0 | 0 |
| Health score | 0 | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.4× | – |
| Growth | ||
| Revenue growth (TTM) | 30.5% | 50.8% (better) |
| Net income growth (TTM) | – | −568% |
| EPS growth (TTM) | – | −541% |
| Profitability | ||
| Gross margin | 60.7% (better) | 41.0% |
| Operating margin | −21.6% | −19.3% (better) |
| Net margin | −46.9% | −22.4% (better) |
| Return on equity | – | −134% |
| Financial health | ||
| Debt / equity | – | 1.79 |
| Current ratio | 0.45 | 0.86 (better) |
| Altman Z-score | −7.33 | – |
| Piotroski F-score | 5 (better) | 3 |
| Dividends and buybacks | ||
| Buyback yield | −15.2% | – |
| Shareholder yield | −15.2% | – |
| Ownership | ||
| Held by institutions | – | 0.01% |
| Held by insiders | 23.8% | 72.3% |
| Insider net buying, 12 months | $43.2K | – |
Go deeper
- RDZN stock overview
- RDZN income statement
- RDZN valuation and score
- ZBAO stock overview
- ZBAO income statement
- ZBAO valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.